Novartis' strong drug pipeline and financials support an 11% annual return by 2027. Learn why NVS stock offers 33% return ...

This advertisement has not loaded yet, but your article continues below. While Acadia’s varsity swimmers and the Wolfville swimming community cope with the news of their pending pool closure and loss ...

If the Department of Education is dismantled, as some Republican lawmakers are hoping to do, public school K-12 educators ...

Alnylam awaits FDA decisions on Amvuttra & Fitusiran next month, poised to boost revenue, profitability, and share growth.

More than 3,000 pages of documents reveal how years of betrayals led to a messy court battle that threatens the future of ...

Officials say a drive to help animals in local shelters was a big success. Donations of food, toys and more were collected at ...

According to Scevoli, these are signs of healthy conflict: Respectful communication: Disagreements focus on solutions rather than personal attacks. Emotional engagement: Both partners feel heard and ...

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) for the first authorized use of an ...

Stock futures were mostly trading in the green Friday as investors leaned into the lack of clarity surrounding President Donald Trump’s plan to impose so-called reciprocal tariffs. Trump signed a memo ...

Ryoncil ® was approved in December 2024 by the United States Food and Drug Administration (FDA) for steroid-refractory acute ...